Utah Medical Products, Inc.
UTMD
$63.12
$0.250.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.47% | -13.68% | 0.23% | 4.79% | -18.55% |
| Total Depreciation and Amortization | -1.17% | 1.45% | 5.13% | -1.23% | -1.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.77% | 441.27% | 53.68% | -202.26% | -- |
| Change in Net Operating Assets | -67.30% | 130.23% | -203.82% | 201.21% | -85.23% |
| Cash from Operations | -10.34% | 34.98% | -35.64% | 51.99% | -23.83% |
| Capital Expenditure | -303.70% | 47.06% | 72.28% | -1,944.44% | 89.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -303.70% | 47.06% | 72.28% | -1,944.44% | 89.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -52.22% | 81.27% | -8.26% | 51.99% | -73.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.11% | 1.30% | 1.57% | 2.02% | 1.33% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.11% | 63.44% | -5.90% | 45.29% | -57.52% |
| Foreign Exchange rate Adjustments | 175.41% | -123.46% | 69.38% | 146.73% | -271.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.69% | 282.20% | -428.37% | 106.37% | -613.95% |